---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T01:50:37.692065'
end_time: '2025-12-27T01:54:46.854232'
duration_seconds: 249.16
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: POLDIP2
  gene_symbol: POLDIP2
  uniprot_accession: Q9Y2S7
  protein_description: 'RecName: Full=Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527};
    AltName: Full=38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211};
    Short=p38 {ECO:0000303|PubMed:12522211}; Flags: Precursor;'
  gene_info: Name=POLDIP2 {ECO:0000303|PubMed:26984527, ECO:0000312|HGNC:HGNC:23781};
    Synonyms=PDIP38 {ECO:0000303|PubMed:12522211, ECO:0000303|PubMed:16428295}, POLD4;
    ORFNames=HSPC017;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: ApaG_domain. (IPR007474); ApaG_sf. (IPR036767); Hemimethylated_DNA-bd_dom.
    (IPR011722); Hemimethylated_DNA-bd_sf. (IPR036623); DUF525 (PF04379)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 10
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9Y2S7
- **Protein Description:** RecName: Full=Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527}; AltName: Full=38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211}; Short=p38 {ECO:0000303|PubMed:12522211}; Flags: Precursor;
- **Gene Information:** Name=POLDIP2 {ECO:0000303|PubMed:26984527, ECO:0000312|HGNC:HGNC:23781}; Synonyms=PDIP38 {ECO:0000303|PubMed:12522211, ECO:0000303|PubMed:16428295}, POLD4; ORFNames=HSPC017;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** ApaG_domain. (IPR007474); ApaG_sf. (IPR036767); Hemimethylated_DNA-bd_dom. (IPR011722); Hemimethylated_DNA-bd_sf. (IPR036623); DUF525 (PF04379)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "POLDIP2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'POLDIP2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **POLDIP2** (gene ID: POLDIP2, UniProt: Q9Y2S7) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9Y2S7
- **Protein Description:** RecName: Full=Polymerase delta-interacting protein 2 {ECO:0000303|PubMed:26984527}; AltName: Full=38 kDa DNA polymerase delta interaction protein {ECO:0000303|PubMed:12522211}; Short=p38 {ECO:0000303|PubMed:12522211}; Flags: Precursor;
- **Gene Information:** Name=POLDIP2 {ECO:0000303|PubMed:26984527, ECO:0000312|HGNC:HGNC:23781}; Synonyms=PDIP38 {ECO:0000303|PubMed:12522211, ECO:0000303|PubMed:16428295}, POLD4; ORFNames=HSPC017;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** ApaG_domain. (IPR007474); ApaG_sf. (IPR036767); Hemimethylated_DNA-bd_dom. (IPR011722); Hemimethylated_DNA-bd_sf. (IPR036623); DUF525 (PF04379)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "POLDIP2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'POLDIP2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **POLDIP2** (gene ID: POLDIP2, UniProt: Q9Y2S7) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Human POLDIP2 (Q9Y2S7)

Identity verification and nomenclature
- Target confirmed as human polymerase delta–interacting protein 2 (POLDIP2; also historically PDIP38/PolDIP2), originally identified as a binding partner of the p50 subunit of DNA polymerase δ and associated with PCNA in the nucleus (supporting the polymerase delta–interacting identity) (wuttinontananchai2025genomewidecrisprscreen pages 13-14, wuttinontananchai2025genomewidecrisprscreen pages 11-12). The requested organism context (Homo sapiens) and gene symbol match the literature cited below. Domain-level details such as ApaG/DUF525 and hemimethylated-DNA-binding–like folds are consistent with the UniProt record provided by the requester, but recent sources in the gathered evidence do not further elaborate these domains; thus, domain inferences here remain based on UniProt and are noted as such.

Key concepts and definitions (current understanding)
- Multifunctional scaffold at the interface of DNA replication/repair, replication stress tolerance, RNA processing, and redox signaling: In the nucleus, POLDIP2 binds Pol δ (p50) and associates with PCNA, linking it to coordination of DNA replication/repair and translesion synthesis via reported interaction with Pol η. It also functionally connects to repriming through PrimPol, though recruitment to UV damage sites can be context-dependent. Beyond DNA metabolism, it can translocate to spliceosomes and regulate UV-induced alternative splicing (e.g., MDM2). In mitochondria and cytoplasm, POLDIP2 interacts with p22phox to enhance NOX4 activity and ROS production, integrating replication stress biology with cellular redox signaling (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).

Recent developments and latest research (2023–2025)
- Post-transcriptional regulation via alternative polyadenylation (APA): A 2025 genome-wide CRISPR screen identified POLDIP2 as a novel APA regulator that globally affects 3′ UTR selection. Knockdown increased CD47 protein and favored the short 3′ UTR isoform, with transcriptome-wide bidirectional APA changes, suggesting a scaffolding role in PAS selection despite lacking a canonical RNA-binding domain (Scientific Reports; Aug 2025; https://doi.org/10.1038/s41598-025-14782-7) (wuttinontananchai2025genomewidecrisprscreen pages 11-12).
- Endothelial inflammation and COVID-19 pathobiology: A 2025 preprint reports that Poldip2 haploinsufficiency in hACE2 mice attenuates SARS‑CoV‑2–induced disease severity without altering viral load, reducing neutrophil infiltration and inflammatory cytokines. The study frames POLDIP2 as a modulator of vascular inflammation, consistent with prior BBB/vascular permeability literature referenced therein (bioRxiv; Jun 2025; https://doi.org/10.1101/2025.06.17.657579) (hu2025poldip2deficiencyattenuates pages 16-19).
- AMD-related oxidative stress in human RPE: CRISPR/Cas9 POLDIP2 knockout in ARPE‑19 cells reduced mitochondrial superoxide (MitoSOX) and was associated with SOD2 upregulation and immune/complement transcriptional changes, supporting a role for POLDIP2 in retinal oxidative stress pathways relevant to AMD (Aging; Feb 2023; https://doi.org/10.18632/aging.204522) (nguyen2023knockoutofamdassociated pages 8-10, nguyen2023knockoutofamdassociated pages 13-14).

Biochemical functions and interactions
- Replication/repair machinery: POLDIP2 binds the p50 subunit of Pol δ and associates with PCNA, situating it within replisome-associated processes, including DNA damage tolerance/TLS via Pol η and coordination with repriming polymerase PrimPol. Reports differ on UV-damage recruitment, indicating regulation may be context- or stimulus-specific (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).
- Redox signaling: POLDIP2 binds the C-terminal tail of p22phox to enhance NOX4 enzymatic activity, increasing ROS output. This biochemical interaction provides a molecular pathway linking POLDIP2 to vascular cell signaling, barrier function, and inflammatory responses (wuttinontananchai2025genomewidecrisprscreen pages 11-12).
- RNA processing: POLDIP2 can relocalize to spliceosomes and regulate alternative splicing (e.g., MDM2) under UV; more recently, it acts as a global APA regulator that alters 3′ UTR landscapes, influencing protein output (wuttinontananchai2025genomewidecrisprscreen pages 11-12).

Roles in DNA replication/repair and replication stress tolerance
- By interacting with PCNA and TLS polymerases, and by modulating PrimPol-dependent repriming, POLDIP2 is positioned to facilitate replication across DNA lesions and to integrate replication stress responses. The functional footprint includes coordination of DNA replication and repair and broader replication stress/DNA damage response programs (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).

Mitochondrial functions and ROS regulation
- POLDIP2 promotes NOX4-dependent ROS generation via p22phox binding; in human retinal pigment epithelium, POLDIP2 knockout reduces mitochondrial superoxide and upregulates SOD2, indicating POLDIP2 as a positive regulator of oxidative tone and linking it to retinal disease biology (wuttinontananchai2025genomewidecrisprscreen pages 11-12, nguyen2023knockoutofamdassociated pages 8-10).

Subcellular localization
- Nuclear and mitochondrial/cytoplasmic pools: POLDIP2 displays subcellular dynamics, with nuclear localization for DNA replication/repair and RNA processing roles, and mitochondrial/cytosolic activities for ROS regulation via NOX4–p22phox (wuttinontananchai2025genomewidecrisprscreen pages 11-12).

Pathway integration
- DNA replication and damage tolerance: Integration with Pol δ, PCNA, TLS (Pol η), and PrimPol positions POLDIP2 within replication fork progression, repriming, and lesion bypass mechanisms (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).
- Redox/vascular signaling: Through NOX4 activation, POLDIP2 contributes to ROS-dependent signaling cascades that affect endothelial/vascular function and inflammation (wuttinontananchai2025genomewidecrisprscreen pages 11-12, hu2025poldip2deficiencyattenuates pages 16-19).
- Post-transcriptional gene regulation: POLDIP2’s roles in splicing and APA broaden its regulatory scope to transcript fate and protein expression profiles during stress responses (wuttinontananchai2025genomewidecrisprscreen pages 11-12).

Current applications and real-world implementations
- Disease modeling/therapeutic exploration:
  - AMD: Human RPE POLDIP2 knockout models demonstrate reduced mitochondrial superoxide and altered inflammatory/complement gene expression, motivating POLDIP2 as a potential modulator of retinal oxidative stress and a candidate for mechanistic/therapeutic studies (Aging; 2023; https://doi.org/10.18632/aging.204522) (nguyen2023knockoutofamdassociated pages 8-10, nguyen2023knockoutofamdassociated pages 13-14).
  - COVID-19 inflammation: Genetic reduction of Poldip2 mitigated disease severity in a mouse SARS‑CoV‑2 model, suggesting that POLDIP2-dependent vascular inflammation could be a target; this remains preclinical (bioRxiv; 2025; https://doi.org/10.1101/2025.06.17.657579) (hu2025poldip2deficiencyattenuates pages 16-19).
  - APA biomarkers/regulators: The 2025 CRISPR screen positions POLDIP2 as a regulator of APA with measurable effects on CD47 surface expression, indicating utility in functional genomics screens of post-transcriptional regulation and potentially in immunobiology contexts where CD47 is relevant (Sci Rep; 2025; https://doi.org/10.1038/s41598-025-14782-7) (wuttinontananchai2025genomewidecrisprscreen pages 11-12).

Expert opinions and analysis from authoritative sources
- A 2025 peer-reviewed study frames POLDIP2 as a multifunctional, subcellularly dynamic scaffold that coordinates DNA replication/repair, RNA processing (splicing/APA), and mitochondrial ROS production via NOX4. The same study synthesizes earlier biochemical work and presents new APA data, emphasizing scaffolding as a unifying principle (Sci Rep; 2025; https://doi.org/10.1038/s41598-025-14782-7) (wuttinontananchai2025genomewidecrisprscreen pages 11-12).
- Preclinical vascular studies suggest that POLDIP2’s redox functions underlie endothelial barrier regulation and inflammation relevant to infectious and ischemic insults, aligning with prior endothelial/BBB permeability literature referenced in 2025 work (bioRxiv; 2025; https://doi.org/10.1101/2025.06.17.657579) (hu2025poldip2deficiencyattenuates pages 16-19).

Relevant statistics and data from recent studies
- AMD/RPE model: POLDIP2 knockout ARPE‑19 cells showed a reduction in mitochondrial superoxide measured by MitoSOX (2 biological experiments, each with 3 technical replicates) and increased SOD2 expression; transcriptomics revealed immune/complement pathway changes (Aging; 2023; https://doi.org/10.18632/aging.204522) (nguyen2023knockoutofamdassociated pages 8-10).
- APA regulation: POLDIP2 knockdown increased CD47 protein abundance and shifted isoform usage toward the short 3′ UTR; transcriptome-wide effects included both 3′ UTR shortening and lengthening, highlighting a global role in APA (Sci Rep; 2025; https://doi.org/10.1038/s41598-025-14782-7) (wuttinontananchai2025genomewidecrisprscreen pages 11-12).
- COVID-19 model: Poldip2+/− hACE2 mice exhibited attenuated disease severity metrics (reduced neutrophil infiltration/chemokines) with unchanged viral load; quantitative details are in the preprint’s figures and supplements (bioRxiv; 2025; https://doi.org/10.1101/2025.06.17.657579) (hu2025poldip2deficiencyattenuates pages 16-19).

Disease relevance
- Vascular permeability and inflammation: Genetic reduction of Poldip2 ameliorates inflammatory injury in SARS‑CoV‑2 infection models and aligns with prior observations that POLDIP2 regulates endothelial/BBB permeability through ROS-linked effects (hu2025poldip2deficiencyattenuates pages 16-19).
- Age-related macular degeneration (AMD): POLDIP2 KO decreases mitochondrial superoxide and reshapes immune/complement transcriptional programs in human RPE, supporting a contributory role to AMD pathogenesis via oxidative signaling (nguyen2023knockoutofamdassociated pages 8-10, nguyen2023knockoutofamdassociated pages 13-14).
- Cancer and replication stress: Through interactions with PCNA/TLS polymerases and regulation of PrimPol-mediated repriming, POLDIP2 interfaces with replication stress tolerance mechanisms relevant to tumor biology; recent APA findings further implicate it in post-transcriptional regulation impacting oncogenic pathways (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).

Limitations and open questions
- Structural domain details (e.g., ApaG/DUF525; hemimethylated DNA-binding–like folds) and high-resolution structures were not detailed in the recent sources captured here; interpretations relying on domain architecture are therefore limited to UniProt annotations provided by the requester and should be updated as structural studies emerge (wuttinontananchai2025genomewidecrisprscreen pages 11-12, wuttinontananchai2025genomewidecrisprscreen pages 13-14).
- Some vascular/BBB claims are based on a 2025 preprint that references earlier peer‑reviewed studies; while consistent with prior literature, the specific new results await peer review (hu2025poldip2deficiencyattenuates pages 16-19).

References (with URLs and publication dates)
- Wuttinontananchai C, Yamamoto J, Sakamoto S, Yamaguchi Y. Genome-wide CRISPR screen for human factors involved in alternative polyadenylation based on differential localization of CD47. Scientific Reports. Aug 2025. https://doi.org/10.1038/s41598-025-14782-7 (wuttinontananchai2025genomewidecrisprscreen pages 11-12)
- Hu R, Valdivia A, White T, et al. Poldip2 deficiency attenuates disease severity in a mouse model of COVID-19. bioRxiv. Jun 2025. https://doi.org/10.1101/2025.06.17.657579 (hu2025poldip2deficiencyattenuates pages 16-19)
- Nguyen T, Urrutia-Cabrera D, Wang L, et al. Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. Aging. Feb 2023;15:1713–1733. https://doi.org/10.18632/aging.204522 (nguyen2023knockoutofamdassociated pages 8-10, nguyen2023knockoutofamdassociated pages 13-14)
- Additional background on Pol δ/PCNA/TLS/PrimPol and historical PDIP38 nomenclature summarized in the Scientific Reports 2025 article’s literature context (wuttinontananchai2025genomewidecrisprscreen pages 13-14).


References

1. (wuttinontananchai2025genomewidecrisprscreen pages 13-14): Chayanin Wuttinontananchai, Junichi Yamamoto, Satoshi Sakamoto, and Yuki Yamaguchi. Genome-wide crispr screen for human factors involved in alternative polyadenylation based on differential localization of cd47. Scientific Reports, Aug 2025. URL: https://doi.org/10.1038/s41598-025-14782-7, doi:10.1038/s41598-025-14782-7. This article has 1 citations and is from a peer-reviewed journal.

2. (wuttinontananchai2025genomewidecrisprscreen pages 11-12): Chayanin Wuttinontananchai, Junichi Yamamoto, Satoshi Sakamoto, and Yuki Yamaguchi. Genome-wide crispr screen for human factors involved in alternative polyadenylation based on differential localization of cd47. Scientific Reports, Aug 2025. URL: https://doi.org/10.1038/s41598-025-14782-7, doi:10.1038/s41598-025-14782-7. This article has 1 citations and is from a peer-reviewed journal.

3. (hu2025poldip2deficiencyattenuates pages 16-19): Ruinan Hu, Alejandra Valdivia, Taylor White, Willy Ju, Maegan L. Brockman, Zhan Zhang, Hongyan Qu, Georgette Gafford, Giji Joseph, Samantha Burton, Leda Bassit, Tysheena P. Charles, Rebecca D. Levit, Cynthia A. Derdeyn, Kathy K. Griendling, Bernard Lassègue, and Marina S. Hernandes. Poldip2 deficiency attenuates disease severity in a mouse model of covid-19. bioRxiv, Jun 2025. URL: https://doi.org/10.1101/2025.06.17.657579, doi:10.1101/2025.06.17.657579. This article has 0 citations and is from a poor quality or predatory journal.

4. (nguyen2023knockoutofamdassociated pages 8-10): Tu Nguyen, Daniel Urrutia-Cabrera, Luozixian Wang, Jarmon G. Lees, Jiang-Hui Wang, Sandy S.C. Hung, Alex W. Hewitt, Thomas L. Edwards, Sam McLenachan, Fred K. Chen, Shiang Y. Lim, Chi D. Luu, Robyn Guymer, and Raymond C.B. Wong. Knockout of amd-associated gene poldip2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. Aging, 15:1713-1733, Feb 2023. URL: https://doi.org/10.18632/aging.204522, doi:10.18632/aging.204522. This article has 2 citations and is from a peer-reviewed journal.

5. (nguyen2023knockoutofamdassociated pages 13-14): Tu Nguyen, Daniel Urrutia-Cabrera, Luozixian Wang, Jarmon G. Lees, Jiang-Hui Wang, Sandy S.C. Hung, Alex W. Hewitt, Thomas L. Edwards, Sam McLenachan, Fred K. Chen, Shiang Y. Lim, Chi D. Luu, Robyn Guymer, and Raymond C.B. Wong. Knockout of amd-associated gene poldip2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. Aging, 15:1713-1733, Feb 2023. URL: https://doi.org/10.18632/aging.204522, doi:10.18632/aging.204522. This article has 2 citations and is from a peer-reviewed journal.

## Citations

1. wuttinontananchai2025genomewidecrisprscreen pages 11-12
2. nguyen2023knockoutofamdassociated pages 8-10
3. wuttinontananchai2025genomewidecrisprscreen pages 13-14
4. nguyen2023knockoutofamdassociated pages 13-14
5. https://doi.org/10.1038/s41598-025-14782-7
6. https://doi.org/10.1101/2025.06.17.657579
7. https://doi.org/10.18632/aging.204522
8. https://doi.org/10.1038/s41598-025-14782-7,
9. https://doi.org/10.1101/2025.06.17.657579,
10. https://doi.org/10.18632/aging.204522,